 | • レポートコード：B-GIR09D4030 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、炎症性皮膚疾患薬の世界市場について調べ、まとめました。種類別セグメントは、レチノイド、コルチコステロイド、カルシニューリン阻害剤、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。炎症性皮膚疾患薬の世界市場概観、企業動向、企業別炎症性皮膚疾患薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・炎症性皮膚疾患薬の市場概観 ・炎症性皮膚疾患薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・炎症性皮膚疾患薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・炎症性皮膚疾患薬の世界市場規模 ・炎症性皮膚疾患薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・炎症性皮膚疾患薬のアメリカ市場規模推移 ・炎症性皮膚疾患薬のカナダ市場規模推移 ・炎症性皮膚疾患薬のメキシコ市場規模推移 ・炎症性皮膚疾患薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・炎症性皮膚疾患薬のドイツ市場規模推移 ・炎症性皮膚疾患薬のイギリス市場規模推移 ・炎症性皮膚疾患薬のロシア市場規模推移 ・炎症性皮膚疾患薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・炎症性皮膚疾患薬の日本市場規模推移 ・炎症性皮膚疾患薬の中国市場規模推移 ・炎症性皮膚疾患薬の韓国市場規模推移 ・炎症性皮膚疾患薬のインド市場規模推移 ・炎症性皮膚疾患薬の東南アジア市場規模推移 ・炎症性皮膚疾患薬の南米市場分析（ブラジル、アルゼンチン等） ・炎症性皮膚疾患薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・炎症性皮膚疾患薬の種類別分析/販売量、売上、市場シェア（レチノイド、コルチコステロイド、カルシニューリン阻害剤、その他） ・炎症性皮膚疾患薬の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局） ・炎症性皮膚疾患薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・炎症性皮膚疾患薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Inflammatory Skin Diseases Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Inflammatory Skin Diseases Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Inflammatory Skin Diseases Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Inflammatory Skin Diseases Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
Merck
AbbVie
Novartis
Boehringer Ingelheim
Amgen
Eli Lilly
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Retinoids
Corticosteroids
Calcineurin Inhibitors
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Table of Contents
1 Inflammatory Skin Diseases Drugs Market Overview
1.1 Product Overview and Scope of Inflammatory Skin Diseases Drugs
1.2 Classification of Inflammatory Skin Diseases Drugs by Types
1.2.1 Global Inflammatory Skin Diseases Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Inflammatory Skin Diseases Drugs Revenue Market Share by Types in 2018
1.2.3 Retinoids
1.2.4 Corticosteroids
1.2.5 Calcineurin Inhibitors
1.2.6 Others
1.3 Global Inflammatory Skin Diseases Drugs Market by Application
1.3.1 Global Inflammatory Skin Diseases Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Inflammatory Skin Diseases Drugs Market by Regions
1.4.1 Global Inflammatory Skin Diseases Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Inflammatory Skin Diseases Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Inflammatory Skin Diseases Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Inflammatory Skin Diseases Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Inflammatory Skin Diseases Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Inflammatory Skin Diseases Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Inflammatory Skin Diseases Drugs (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Inflammatory Skin Diseases Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck
2.2.1 Business Overview
2.2.2 Inflammatory Skin Diseases Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 AbbVie
2.3.1 Business Overview
2.3.2 Inflammatory Skin Diseases Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AbbVie Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Inflammatory Skin Diseases Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Inflammatory Skin Diseases Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 Amgen
2.6.1 Business Overview
2.6.2 Inflammatory Skin Diseases Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Amgen Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.7 Eli Lilly
2.7.1 Business Overview
2.7.2 Inflammatory Skin Diseases Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eli Lilly Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Inflammatory Skin Diseases Drugs Market Competition, by Players
3.1 Global Inflammatory Skin Diseases Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Inflammatory Skin Diseases Drugs Players Market Share
3.2.2 Top 10 Inflammatory Skin Diseases Drugs Players Market Share
3.3 Market Competition Trend
4 Global Inflammatory Skin Diseases Drugs Market Size by Regions
4.1 Global Inflammatory Skin Diseases Drugs Revenue and Market Share by Regions
4.2 North America Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
5 North America Inflammatory Skin Diseases Drugs Revenue by Countries
5.1 North America Inflammatory Skin Diseases Drugs Revenue by Countries (2014-2019)
5.2 USA Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
6 Europe Inflammatory Skin Diseases Drugs Revenue by Countries
6.1 Europe Inflammatory Skin Diseases Drugs Revenue by Countries (2014-2019)
6.2 Germany Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
6.4 France Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Inflammatory Skin Diseases Drugs Revenue by Countries
7.1 Asia-Pacific Inflammatory Skin Diseases Drugs Revenue by Countries (2014-2019)
7.2 China Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
7.5 India Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
8 South America Inflammatory Skin Diseases Drugs Revenue by Countries
8.1 South America Inflammatory Skin Diseases Drugs Revenue by Countries (2014-2019)
8.2 Brazil Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Inflammatory Skin Diseases Drugs by Countries
9.1 Middle East and Africa Inflammatory Skin Diseases Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
10 Global Inflammatory Skin Diseases Drugs Market Segment by Type
10.1 Global Inflammatory Skin Diseases Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Inflammatory Skin Diseases Drugs Market Forecast by Type (2019-2024)
10.3 Retinoids Revenue Growth Rate (2014-2024)
10.4 Corticosteroids Revenue Growth Rate (2014-2024)
10.5 Calcineurin Inhibitors Revenue Growth Rate (2014-2024)
10.6 Others Revenue Growth Rate (2014-2024)
11 Global Inflammatory Skin Diseases Drugs Market Segment by Application
11.1 Global Inflammatory Skin Diseases Drugs Revenue Market Share by Application (2014-2019)
11.2 Inflammatory Skin Diseases Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Retail Pharmacies Revenue Growth (2014-2019)
11.5 Online Pharmacies Revenue Growth (2014-2019)
12 Global Inflammatory Skin Diseases Drugs Market Size Forecast (2019-2024)
12.1 Global Inflammatory Skin Diseases Drugs Market Size Forecast (2019-2024)
12.2 Global Inflammatory Skin Diseases Drugs Market Forecast by Regions (2019-2024)
12.3 North America Inflammatory Skin Diseases Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Inflammatory Skin Diseases Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Inflammatory Skin Diseases Drugs Revenue Market Forecast (2019-2024)
12.6 South America Inflammatory Skin Diseases Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Inflammatory Skin Diseases Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Inflammatory Skin Diseases Drugs Picture
Table Product Specifications of Inflammatory Skin Diseases Drugs
Table Global Inflammatory Skin Diseases Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Inflammatory Skin Diseases Drugs Revenue Market Share by Types in 2018
Figure Retinoids Picture
Figure Corticosteroids Picture
Figure Calcineurin Inhibitors Picture
Figure Others Picture
Table Global Inflammatory Skin Diseases Drugs Revenue (Million USD) by Application (2014-2024)
Figure Inflammatory Skin Diseases Drugs Revenue Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Inflammatory Skin Diseases Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Inflammatory Skin Diseases Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Inflammatory Skin Diseases Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Inflammatory Skin Diseases Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Inflammatory Skin Diseases Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Inflammatory Skin Diseases Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Inflammatory Skin Diseases Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Inflammatory Skin Diseases Drugs Type and Applications
Table Pfizer Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Inflammatory Skin Diseases Drugs Type and Applications
Table Merck Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Inflammatory Skin Diseases Drugs Type and Applications
Table AbbVie Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Inflammatory Skin Diseases Drugs Type and Applications
Table Novartis Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Inflammatory Skin Diseases Drugs Type and Applications
Table Boehringer Ingelheim Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Inflammatory Skin Diseases Drugs Type and Applications
Table Amgen Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Inflammatory Skin Diseases Drugs Type and Applications
Table Eli Lilly Inflammatory Skin Diseases Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Inflammatory Skin Diseases Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Inflammatory Skin Diseases Drugs Revenue Share by Players (2014-2019)
Figure Global Inflammatory Skin Diseases Drugs Revenue Share by Players in 2017
Figure Global Inflammatory Skin Diseases Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Inflammatory Skin Diseases Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Inflammatory Skin Diseases Drugs Revenue Market Share in 2018
Figure Global Inflammatory Skin Diseases Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Inflammatory Skin Diseases Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Inflammatory Skin Diseases Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Inflammatory Skin Diseases Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Inflammatory Skin Diseases Drugs Revenue Market Share by Regions in 2018
Figure North America Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure South America Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Table North America Inflammatory Skin Diseases Drugs Revenue by Countries (2014-2019)
Table North America Inflammatory Skin Diseases Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Inflammatory Skin Diseases Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Inflammatory Skin Diseases Drugs Revenue Market Share by Countries in 2018
Figure USA Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Table Europe Inflammatory Skin Diseases Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Inflammatory Skin Diseases Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Inflammatory Skin Diseases Drugs Revenue Market Share by Countries in 2018
Figure Germany Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure UK Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure France Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Inflammatory Skin Diseases Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Inflammatory Skin Diseases Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Inflammatory Skin Diseases Drugs Revenue Market Share by Countries in 2018
Figure China Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure India Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Table South America Inflammatory Skin Diseases Drugs Revenue by Countries (2014-2019)
Table South America Inflammatory Skin Diseases Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Inflammatory Skin Diseases Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Inflammatory Skin Diseases Drugs Revenue Market Share by Countries in 2018
Figure Brazil Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Inflammatory Skin Diseases Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Inflammatory Skin Diseases Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Inflammatory Skin Diseases Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Inflammatory Skin Diseases Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Inflammatory Skin Diseases Drugs Revenue and Growth Rate (2014-2019)
Table Global Inflammatory Skin Diseases Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Inflammatory Skin Diseases Drugs Revenue Share by Type (2014-2019)
Figure Global Inflammatory Skin Diseases Drugs Revenue Share by Type (2014-2019)
Figure Global Inflammatory Skin Diseases Drugs Revenue Share by Type in 2019
Table Global Inflammatory Skin Diseases Drugs Revenue Forecast by Type (2019-2024)
Figure Global Inflammatory Skin Diseases Drugs Market Share Forecast by Type (2019-2024)
Figure Global Retinoids Revenue Growth Rate (2014-2019)
Figure Global Corticosteroids Revenue Growth Rate (2014-2019)
Figure Global Calcineurin Inhibitors Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Inflammatory Skin Diseases Drugs Revenue by Application (2014-2019)
Table Global Inflammatory Skin Diseases Drugs Revenue Share by Application (2014-2019)
Figure Global Inflammatory Skin Diseases Drugs Revenue Share by Application (2014-2019)
Figure Global Inflammatory Skin Diseases Drugs Revenue Share by Application in 2019
Table Global Inflammatory Skin Diseases Drugs Revenue Forecast by Application (2019-2024)
Figure Global Inflammatory Skin Diseases Drugs Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Inflammatory Skin Diseases Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Inflammatory Skin Diseases Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Inflammatory Skin Diseases Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Inflammatory Skin Diseases Drugs Revenue Market Forecast (2019-2024)
Figure Europe Inflammatory Skin Diseases Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Inflammatory Skin Diseases Drugs Revenue Market Forecast (2019-2024)
Figure South America Inflammatory Skin Diseases Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Inflammatory Skin Diseases Drugs Revenue Market Forecast (2019-2024)
世界の炎症性皮膚疾患治療市場予測（～2024年） Scope of the Report: The global Inflammatory Skin Diseases Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especiall…- 免疫介在性炎症性疾患治療市場：世界及び中国市場分析・予測（～2024年） Immune Mediated Inflammatory Diseases Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Immune Mediated Inflammatory Diseases Treatment industry with a focus on the Chinese market. The report provides key statistics on…
- 世界の非ステロイド系抗炎症薬（NSAID）市場予測（～2024年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 世界の抗炎症薬市場予測（～2024年） Antiinflammatory Drugs are drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Scope of the Report: The global Antiinflammatory Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% bet…
- 非ステロイド性抗炎症治療薬市場：世界及び中国市場分析・予測（～2024年） Nonsteroidal Anti-inflammatory Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Nonsteroidal Anti-inflammatory Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of th…